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Summary.-110 consecutively diagnosed breast-cancer patients in all stages were
included in a study to evaluate a selective surgical and radiotherapeutical treatment.
The surgical treatment was total mastectomy and exploration of the axilla, with
lymphnode biopsy and peroperative cytological examination. Axillary dissection
was done only when this examination showed metastases. No radiotherapy was
given to the axilla in patients with lateral cancers in the absence of metastases, or
with limited metastasization (no periglandular growth, no growth in apical nodes).
In medial and central cancers, radiotherapy was applied to the parasternal and
supraclavicular nodes irrespective of axillary involvement. A staging system with
a combined clinical and histopathological classification was used and formed the
basis for the selective treatment.
The corrected 5-year survival for the whole material was 80%, for those without
axillary metastasis (Stage I) 950% and for those with axillary metastasis (Stage II)
68%. Six women were alive with known distant metastases. Of 63 patients without
identified axillary metastases at the time of surgery, axillay recurrences occurred in
only3 (50%). It was concluded that patients without axillary metastases can be reliably
selected by the peroperative examination used, and that in this group simple mastec-
tomy results in a high disease-free survival. Early diagnosis and a possible beneficial
effect of the actual therapeutic programme might both have contributed to the high
overall survival.
THE TREATMENT of operable breast
carcinoma has in most earlier studies
been the same, irrespective of tumour
location, size and axillary involvement.
Different classification systems, or the
absence of tumour classification, have
made comparisons between different mat-
erials difficult. It has very often been
stated that the end result is independent
of the type of treatment. However, some
studies, though not randomized, have
shown superior treatment results (e.g.
Gray & Anglem, 1959; Haagensen et al.,
1969). Furthermore, the survival rate has
shown a definite tendency to improve
decade by decade during this century
(Mansfield, 1976). This improvement can
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certainly be attributed mainly to early
diagnosis.
In randomized studies, no significant
differences in survival between different
modes of treatment have been demon-
strated. Even if a difference in fact
should exist, several factors are apt to
conceal it. Breast carcinoma is a hetero-
geneous disease. We have to accept that
the biological characteristics ofthe tumour
to a great extent decide the outcome.
Some of the cancers should, however, be
within those limits which the treatment
can affect. It is absolutely unknown
what percentage of the cancers belong
to this category, but thefrequency may be
influenced by the mode of treatment.
Department of Surgery, University Hospital, S-750SELECTIVE TREATMENT IN BREAST CARCINOMA
The present study was undertaken to
evaluate a differentiated treatment, based
primarily on tumour location and axillary-
node involvement. Primary emphasis was
put on the overall 5-year survival and
recurrence rate in this unselected series,
and on the possibility of a reliable pero-
perative assessment of axillary-node in-
volvement as the basis for surgical
treatment of the axilla. The definite
evaluation of the differentiated treatment
programme used in this study needs, of
course, the design of a randomized trial.
The large number of patients needed to
assure relevant differences in survival to
be detected (e.g. Graffman & Jung, 1970)
and the difficulty in obtaining a standard-
ized handling of patients in a multicentre
study did, however, make this analysis of
a properly controlled pilot study interest-
ing.
PATIENTS AND METHODS
116 women with primary breast carcinoma
were treated at the Departments of Surgery
and Oncology, University Hospital, Uppsala,
Sweden from August 1972 to October 1973.
They represented the total material of newly
detected breast carcinoma cases in Uppsala
county during this period. Two patients
died before any treatment; one from pan-
creatitis and the other from advanced liver
metastases. Four patients did not accept the
recommended therapy. Thus, 6 patients in
all were excluded from the present study,
which included 110 patients.
The mean age was 60-3 ± 14-5 years
(range 27-91 at the time of diagnosis; 32
(29%) were under the age of 50 and 35 (32%)
were premenopausal.
The diagnostic examination were con-
centrated in a special out-patient clinic,
where all women with breast symptoms were
allowed to seek an examination without
previous referral, with a waiting time of
only a few days. Clinical examination, fine-
needle biopsy with cytological examination
and mammography, was performed in close
cooperation between a few physicians at the
first consultation (Johansson et al., 1975;
Rimsten et al., 1975).
The size of the tumours was measured at
examination before the treatment, and was
also obtained form the pathological specimen.
The mean palpatory size was 2-3 i 1-6 cm
and the mean pathological measure 2-2 + 1-3
cm. 67 tumours were located in the lateral
part of the breast and 43 in the medial or
central part.
The cancers were classified according to the
Columbia Clinical Classification (Haagensen,
1971). 76 of the cancers were classified as
Stage A, 23 as Stage B, 7 as Stage C and 4
as Stage D. Of the 6 patients excluded from
the study, 3 belonged to Stage A, 1 to Stage
B and 2 to Stage D.
After surgical treatment the patients were
reclassified according to a Combined Clinical
and Histological Classification (Table I).
Histopathology.-Classification was accord-
ing to Ackerman & del Regato (1970) a
further development of a malignancy grading
suggested by Hultborn & Tornberg (1960).
Four patients were classified as Type 1, 3 as
Type II, 56 as Type III:1, 18 as Type III:2
and 29 as Type IV.
Treatment.-The surgical therapy included
total mastectomy with removal of the
pectoral fascia and an exploration of the
axilla. The central node group was first
examined and then the other node groups.
One or more representativenodes were excised
and sent for immediate examination by
imprint cytology (Rimsten et al., 1974;
1976). Axillary dissection was performed
only if the imprint cytology revealed
cancer, and was always done leaving the
pectoral muscles intact (modified radical
mastectomy).
Radiation therapy was given according to
the following scheme. Patients with lateral
cancers in Stages I or Ila received no post-
operative radiation. Patients with medial
cancers in Stages I or Ila were treated with
electrons from a betatron to the parasternal
nodes and with y-radiation from a Cobalt
unit to the supraclavicular nodes. The
treatment was given daily, 5 days a week,
over a period of 3-4 weeks, with a target
dose of 4500 rad, corresponding to a CRE
value between 1510 and 1600 reu (Kirk
et al., 1971). In Stages Ilb and III, radiation
therapy was given in the same way to the
parasternal and supraclavicular nodes and
to the axil'i, for which the target dose was
kept at the same level using the Cobalt unit.
Electron therapy of individualized energy
was given against the skin flaps and thoracic
wall when the cancer grew very near or into
the pectoralmuscle. Theprotocols ofradiation
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TABLE I.-Combined clinical and histopathological classification
Distant
metas-
Stage Primary tumour Axillary metastases tases
I No local tumour No No
complications
Ila As stage I
Ilb As stage I
III Local tumour
complications. Advanced
growth in breast
and/or axilla
IV
therapy could be followed in all cases but 14.
There were 3 patients with lateral car-
cinomas in Stage Ila who received treatment
against the axilla, and 11 with medial car-
cinomas who had no radiation therapy.
Recurrences.-Local and axillary recur-
rences were treated with excision or radio-
therapy, and in some cases local recurrences
with anti-oestrogens. Distant metastases were
primarily treated with hormone therapy. In
the case of treatment failure, cytostatic
treatment was used.
Follow-up.-Patients were followed up at
the Department of Oncology at regular
intervals from 4 years 9 months to 5 years
10 months (only 32 patients were followed
from 4 years 9 months to 4 years 11 months).
Primarily, X-irradiation of the lungs and
skeleton was performed and a laboratory
survey was done. In advanced cases, and in
patients with symptoms, skeleton and liver
scintigrams were also made.
Recurrences were noted as local, axillary
or distant. Local recurrences were those
located within the treatment area (chest
wall, parasternal and supraclavicular). Dis-
tant metastases were skeletal, visceral,
cutaneous and subcutaneous, outside the
treatment area.
The causes of death were recorded and the
survival rate calculated, both crude and
corrected, for the actual number of inter-
current deaths.
RESULTS
Survival
In the total material, 81/110 women
Yes
No periglandular
growth
Apical nodes not
involved
Yes
Periglandular growth
and/or apical
nodes involved
No
No
No
Yes
were alive after 5 years, which corresponds
to a crude survival of 74% (Table II).
When corrected for death due to inter-
current diseases, survival was 80%.
Twenty one patients died from distant
metastases (including 4 initially in Stage
IV). Eight women died from other causes,
without signs of remaining cancer. Six
patients were alive with known distant
metastases (Table III).
Survival related to the two systems of
classification is shown in Tables II and
IV. According to the combined clinical
and histopathological classification (Table
II) the crude 5-year survival was 87%
(55/63) in Stage I. However, in only 3/8
deceased women was death due to breast
cancer; giving a corrected survival of
95%.
Both classification systems showed a
fairly good separation into stages with
significantly different prognosis. The com-
bined classification also dichotomized
Stage II into those without (Ila) and
those with (Ilb) perinodal tumour growth
or apical-node involvement; the crude
survival being 82% (9/11) and 50%
(10/20), respectively. Five of the 8 women
in Stage III and all 4 in Stage IV were
dead at follow-up (Table II).
Axillary recurrences
Only 3/63 patients (5%) with a negative
peroperative exploration (Stage I. and
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TABLE IL.-5-year survival according to the combined clinical and
histopathological classification
Stage No.
0* 4
I 63
IIa 11
b 20
a+b 31
III 8
IV 4
Total 110
Stages 0-III 106
*Cancer in situ
Dead due to
Breast Intercurrent
% cancer disease
4
57
10
18
28
7
4
100
96
3
2
8
10
4
4
21
17
5
2
2
1
8
8
% survival
Crude Corrected
100 100
87 95
82 82
50 58
61 68
38 47
0 0
74 80
78 83
TABLE III.-Local recurrences and axillary and distant metastases after
5 years in Stage 0-III according to the Combined Classification,
with the number ofpatients deadfrom cancer
in parentheses
Recurrences
Stage No.
0
I
Ila
b
III
Total
4
63
La
Local Local + Axillary Local +
only axillary only distant
2 - 2 2 (1)
11 - 1 -
20 1 1 3 (3)
8 - 2 (1)
106 4 (0) 1 4 (0) 7 (5)
thus with no axillary dissection or post-
operative irradiation) had developed axil-
lary recurrence. In one of them this
recurrence preceded the appearance of
visceral metastases, whereas in the other
2 an isolated axillary recurrence occurred
after 6 and 55 months, respectively.
Another4patientswithaxillaryrecurrences
had all had an axillary dissection (Stage
Ila and b) and one of them additional
postoperative radiotherapy against the
axilla (Stage Ilb). Two of these 4 patients
also had known distant metastases at
follow-up. The total frequency of axillary
recurrence was 6% (7/110) (Table III).
Local recurrences
Within 5 years, an isolated local re-
currence developed in 2 patients in Stage
I and 1 in Stage Ilb, whereas local
recurrence in combination with axillary
metastases appeared in 1 (Stage Ila) and
in combination with distant metastases
5~~~~~~~~~~~~~
Axillary + Distant
distant only
2 (1)
2 (1)
3 (2)
3 (1)
2 (1)
5 (5)
3 (3)
13 (10)
in 7 cases. This gives a total frequency of
10% (11/110) (Table II) local recurrences
within 5 years. Five of these patients
died during the observation period.
DISCUSSION
The present study was designed to
evaluate the results of a programme for
selective surgical and radiotherapeutic
treatment, based on the location of the
primary tumour and on the axillary-node
status. Simple mastectomy and modified
radical mastectomy as used in this series
is at present the dominating surgical
treatment for breast carcinoma in Great
Britain and also in Sweden (Adami et al.,
1976; Breast Cancer Symposium, 1969).
In operable breast cancer (Stages I and
II) simple mastectomy has one major
disadvantage: the lack of information
about the state of the axillary nodes,
which is accepted as the main determinant
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TABLE IV.-5-year survival according to the Columbia Clinical Classification
Stage
A
B
C
D
No.
76
23
7
4
69
21
6
4
Total 110 100
Dead due to
Breast Intercurrent
cancer disease
7 6
6 2
4
4 _
21
of survival in breast cancer. Moreover, in
patients with axillary metastases, surgical
exaeresis in combination with postopera-
tive irradiation might be a safer mode of
treatment than postoperative irradiation
alone.
In patients without axillary metastases,
on the other hand, axillary dissection can
be considered as an unnecessary mutilating
procedure, and the excision and irradiation
of uninvolved lymph nodes superfluous.
It does also introduce the risk ofpostopera-
tive arm swelling and restriction of arm
movements. In addition, it has been sug-
gested that the axillary nodes participate
in the immunological defence against
cancer spread (Crile, 1967; Fisher, 1971)
and that postoperative irradiation may be
harmful by suppressing the host response
(Stjernsward, 1974). These data were
considered as contradicting the routine
use of exaeresis or irradiation of the
axilla ifnode metastases couldbeexcluded.
It is well established that the clinical
assessment of axillary-node involvement
is highly uncertain, with at least 30%
false-positive findings and about the same
frequency of false-negatives (Wallace &
Champion, 1972; Silverberg, 1975; Schot-
tenfeld et al., 1976; Freund et al., 1977).
Selective treatment based on axillary-
node status does, therefore, presuppose
that axillary metastases can be diagnosed
at the time of surgery. It was a major
experience from this study, as from a
previous preliminary report (Rimstenetal.,
1976) that this can be done with a high
degree of certainty by peroperative pal-
pation and node biopsies during the
operation. The peroperative examination
of the node biopsies can probably be
°b survival
Crude Corrected
83 90
65 73
43 43
0 0
8 74 80
done with the same degree of accuracy by
frozen-section examination as by the
cytological-imprint technique used in this
study. The axillary recurrence rate of 5%
(3/63) after 5 years in those with negative
biopsies (Stage I) and therefore without
axillary dissection or irradiation, seems
encouraging. This is lower than that ofthe
8% (6/75) reported by Forrest et al.
(1974) after pectoral-node biopsy, with
a shorter observation period than in this
study.
Much of the controversy about breast-
cancer treatment probably has its origin
in the lack of results based on unselected
patient materials. The relative inaccuracy
of clinical staging has further contributed
to the persistent disagreement about the
optimal local primary treatment in breast
cancer. Another factor is the lack of
consequent correction for deaths due to
intercurrent diseases. The possible bene-
ficial effect on survival by active efforts
to obtain an early diagnosis and improved
treatment can best be evaluated within
the frame of randomized trials. Our
present results, based on a restricted
number of patients, thus have to be
considered with some caution, but they
can allow a comparison with other mat-
erials of well-classified tumours.
The overall 5-year survivalinpatients with
operable breast cancer, treated by radical
mastectomy, has varied in different reports
between 49% (Finney et al., 1947) and
74-5% (Gray & Anglem, 1959). Most
series are selected, however, in different
ways, and survival figures based on total
materials are difficult to find. A 5-year
survival of 46-5% was found in total
Swedish material (Nohrman, 1949) and
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a figure of 5500 was later reported by
Kaae & Johansen (1968). A recent study
from Sweden showed a corrected 5-year
survival of 70.7% (Johnsen, 1975). The
corrected survival of 80% in our study
seems anyhow to be higher than that in
most other materials. In addition, only 6
patients are living with known distant
metastases.
Principally, this favourable survival
can be due to the type of treatment used,
and to the early diagnosis which has been
claimedtoaccountforanimprovedsurvival
(Anglem & Leber, 1971; Johnsen, 1975).
Early diagnosis has probably contributed
much to the favourable results in this
study. This is indicated by the relatively
small mean tumour size and by the high
frequency of patients with negative axil-
lary nodes. The present figure of 61% in
this unselected patient material is, in
fact, in close accordance with that of
63% by Strax (1976) in women at annual
screening.
In women without axillary metastases,
the 5-year survival has been 70 ± 10%
in most studies (Mansfield, 1976). A
survival rate 80°/, has been reported
afterboth radical mastectomy (Haagensen
et al., 1969; Payne et al., 1970) and
modified radical mastectomy (Madden
et al., 1972). Our present results indicate
that in Stage I excellent results can be
obtained also by simple mastectomy com-
bined with irradiation to parasternal
and supraclavicular nodes in those with
medially located tumours. Though based
on only 63 cases, it seems unlikely that
the survival could be improved by more
extensive surgery.
The prognosis in breast cancer is
significantly influenced, not only by the
existence ofaxillary metastases, butalsoby
the number ofnodes involved (Haagensen,
1971; Silverberg, 1975) and by their
location in the axilla (Urban, 1960) where
tumour growth in the apical nodes indi-
cates an especially bad prognosis. A de-
tailed assessment of these factors might,
however, be considered inappropriate for
routine use, whereas the recognition of
perinodal tumourgrowth is easily done at a
conventional histopathological examina-
tion. The obvious significance of this
factor on the prognosis has been shown
earlier (e.g. Johnsen, 1975). It is also
evident from this study and is a point of
real interest. The significance of perinodal
growth and the uncertainty of the clinical
assessment of the axillary nodes indicate
the value of the combined clinical and
histopathological classification as sug-
gested in this study. This classification
has a great prognostic significance and
can be used to individualize the treatment.
It can also contribute to a more meaning-
ful comparison between different studies.
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